Skip to main content
Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
41.17
-0.03 (-0.07%)
At close: Apr 28, 2026, 4:00 PM EDT
40.91
-0.26 (-0.63%)
Pre-market: Apr 29, 2026, 8:20 AM EDT

Novo Nordisk Revenue

In the year 2025, Novo Nordisk had annual revenue of 309.06B DKK with 6.43% growth. Novo Nordisk had revenue of 79.14B in the quarter ending December 31, 2025, a decrease of -7.63%.

Revenue (ttm)
309.06B DKK
Revenue Growth
+6.43%
P/S Ratio
3.79
Revenue / Employee
4,446,644 DKK
Employees
69,505
Market Cap
184.25B USD

Revenue Chart

* This company reports financials in DKK.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025309.06B18.66B6.43%
Dec 31, 2024290.40B58.14B25.03%
Dec 31, 2023232.26B55.31B31.26%
Dec 31, 2022176.95B36.15B25.68%
Dec 31, 2021140.80B13.85B10.91%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Johnson & Johnson 96.36B
Merck & Co. 65.01B
Pfizer 62.58B
AbbVie 61.16B
AstraZeneca 58.74B
Novartis AG 56.67B
Sanofi 54.85B
Bristol-Myers Squibb Company 48.19B
Revenue Rankings

NVO News

More News